Asthma management: are GINA guidelines appropriate for daily clinical practice?

[1]  J. Bestall,et al.  Holding chambers versus nebulisers for inhaled steroids in chronic asthma. , 2006, The Cochrane database of systematic reviews.

[2]  B. Yawn,et al.  Measuring asthma quality in primary care: can we develop better measures? , 2006, Respiratory medicine.

[3]  R. Pauwels,et al.  Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma ControL study. , 2004, American journal of respiratory and critical care medicine.

[4]  Kevin B Weiss,et al.  Worldwide severity and control of asthma in children and adults: the global asthma insights and reality surveys. , 2004, The Journal of allergy and clinical immunology.

[5]  D. Fabian,et al.  The global burden of asthma: executive summary of the GINA Dissemination Committee Report , 2004, Allergy.

[6]  F. Gesten,et al.  A survey of Medicaid recipients with asthma: perceptions of self-management, access, and care. , 2004, Chest.

[7]  M. Weatherall,et al.  Dose-response relationship of inhaled budesonide in adult asthma: a meta-analysis , 2004, European Respiratory Journal.

[8]  M. Decramer,et al.  Office spirometry significantly improves early detection of COPD in general practice: the DIDASCO Study. , 2004, Chest.

[9]  K. Bergmann,et al.  Salmeterol/fluticasone propionate (50/250 microg) combination is superior to double dose fluticasone (500 microg) for the treatment of symptomatic moderate asthma. , 2004, Swiss medical weekly.

[10]  C. Griffiths,et al.  Specialist nurse intervention to reduce unscheduled asthma care in a deprived multiethnic area: the east London randomised controlled trial for high risk asthma (ELECTRA) , 2004, BMJ : British Medical Journal.

[11]  Karl-Christian Bergmanna,et al.  Salmeterol/fluticasone propionate (50/250 μg) combination is superior to double dose fluticasone (500 μg) for the treatment of symptomatic moderate asthma , 2004 .

[12]  C. Dinakar,et al.  The yellow zone in asthma treatment: is it a gray zone? , 2004, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[13]  D. Brand,et al.  Classifying asthma: disagreement among specialists. , 2003, Chest.

[14]  P. Dorinsky,et al.  Asthma variability in patients previously treated with beta2-agonists alone. , 2003, The Journal of allergy and clinical immunology.

[15]  A. Chetta,et al.  Inhaled steroids and airway remodelling in asthma. , 2003, Acta bio-medica : Atenei Parmensis.

[16]  H. Bisgaard,et al.  Montelukast and fluticasone compared with salmeterol and fluticasone in protecting against asthma exacerbation in adults: one year, double blind, randomised, comparative trial , 2003, BMJ : British Medical Journal.

[17]  T. Chiba,et al.  Prevalence of esophageal candidiasis among patients treated with inhaled fluticasone propionate , 2003, American Journal of Gastroenterology.

[18]  N. Chavannes,et al.  Validity of spirometric testing in a general practice population of patients with chronic obstructive pulmonary disease (COPD) , 2003, Thorax.

[19]  B. Yawn.  The impact of childhood asthma on daily life of the family-a qualitative study using recurrent thematic analysis. , 2003, Primary care respiratory journal : journal of the General Practice Airways Group.

[20]  H. Kitzman,et al.  Barriers to anti-inflammatory medication use in childhood asthma. , 2003, Ambulatory pediatrics : the official journal of the Ambulatory Pediatric Association.

[21]  H. Kitzman,et al.  Parental perceptions of their child's asthma: management and medication use. , 2003, Journal of pediatric health care : official publication of National Association of Pediatric Nurse Associates & Practitioners.

[22]  I. Naya,et al.  Once-daily budesonide/formoterol in a single inhaler in adults with moderate persistent asthma. , 2003, Respiratory medicine.

[23]  P. Gibson,et al.  Inhaled corticosteroid doses in asthma: an evidence‐based approach , 2003, The Medical journal of Australia.

[24]  E. Bateman,et al.  Combination Therapy with Single Inhaler Budesonide/Formoterol Compared with High Dose of Fluticasone Propionate Alone in Patients with Moderate Persistent Asthma , 2003, American journal of respiratory medicine : drugs, devices, and other interventions.

[25]  I. Grzelewska-Rzymowska,et al.  [Airway remodeling in asthma]. , 2003, Pneumonologia i alergologia polska.

[26]  I. Masters,et al.  Persistent cough in children and the overuse of medications , 2002, Journal of paediatrics and child health.

[27]  C. Acerini,et al.  Survey of adrenal crisis associated with inhaled corticosteroids in the United Kingdom , 2002, Archives of disease in childhood.

[28]  S. Holgate,et al.  Variability and lack of predictive ability of asthma end-points in clinical trials , 2002, European Respiratory Journal.

[29]  L. Boulet,et al.  Evaluation of asthma control by physicians and patients: comparison with current guidelines. , 2002, Canadian respiratory journal.

[30]  M. Goldman,et al.  Within‐ and between‐day variability of respiratory impedance, using impulse oscillometry in adolescent asthmatics , 2002, Pediatric pulmonology.

[31]  Jason S. Krahnke,et al.  Inhaled steroids and the risk of adrenal suppression in children , 2002, Expert opinion on drug safety.

[32]  C. Robertson,et al.  Inhaled steroids — too much of a good thing? , 2002, The Medical journal of Australia.

[33]  S. Bowler.  Inhaled steroids in asthma. Should the doses be reduced? , 2002, Australian family physician.

[34]  W. Busse,et al.  Evolution of dry powder inhaler design, formulation, and performance. , 2002, Respiratory medicine.

[35]  Multicolored simplified asthma guideline reminder (MSAGR) for better adherence to national/global asthma guidelines. , 2002, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[36]  M. Zacharin,et al.  Growth and adrenal suppression in asthmatic children on moderate to high doses of fluticasone propionate , 2002, Journal of paediatrics and child health.

[37]  H. Hoogsteden,et al.  Airway inflammation is present during clinical remission of atopic asthma. , 2001, American journal of respiratory and critical care medicine.

[38]  T. Haahtela,et al.  Asthma programme in Finland: a community problem needs community solutions , 2001, Thorax.

[39]  H R Rubin,et al.  Reasons for pediatrician nonadherence to asthma guidelines. , 2001, Archives of pediatrics & adolescent medicine.

[40]  L. Boulet,et al.  What is new since the last (1999) Canadian Asthma Consensus Guidelines? , 2001, Canadian respiratory journal.

[41]  T. Ahmed,et al.  Mometasone furoate: efficacy and safety in moderate asthma compared with beclomethasone dipropionate. , 2001, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[42]  J. Mertsola,et al.  Regional variation in the diagnosis of asthma among preschool‐age children , 2000, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.

[43]  R. Lin,et al.  Corticosteroid therapy in acute asthma. , 2000, Chest.

[44]  J. Wedzicha,et al.  Feasibility of spirometry and reversibility testing for the identification of patients with chronic obstructive pulmonary disease on asthma registers in general practice. , 1999, Respiratory medicine.

[45]  M. Peterson,et al.  Asthma guidelines: an assessment of physician understanding and practice. , 1999, American journal of respiratory and critical care medicine.

[46]  M. Roghmann,et al.  Adherence to asthma guidelines in general practices. , 1999, The Journal of asthma : official journal of the Association for the Care of Asthma.

[47]  J. Sheller,et al.  Inhaled steroids in asthma. , 1998, Comprehensive therapy.

[48]  D. Postma,et al.  Starting with a higher dose of inhaled corticosteroids in primary care asthma treatment. , 1998, American journal of respiratory and critical care medicine.

[49]  M A Schork,et al.  Impact of education for physicians on patient outcomes. , 1998, Pediatrics.

[50]  J. Bousquet,et al.  Correspondence and requests for reprints should be addressed to Jean Bousquet, , 2022 .

[51]  J. Wever-Hess,et al.  Asthma statistics in The Netherlands 1980-94. , 1997, Respiratory medicine.

[52]  R. Pauwels,et al.  GLOBAL STRATEGY FOR ASTHMA MANAGEMENT AND PREVENTION , 1996 .

[53]  F. Sennhauser,et al.  The Yentl syndrome in childhood asthma: Risk factors for undertreatment in Swiss children , 1995, Pediatric pulmonology.

[54]  R. Dickson,et al.  Scoliosis in the community. , 1983, British medical journal.